SK-GT-4

SK-GT-4

Cat.No.: CSC-C9483J

Species: Homo sapiens (Human)

Source: Esophagus

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9483J
Description
SK-GT-4 was established from a primary tumour in 1989 from a 89 year-old Caucasian male who presented with dysphagia secondary to a well-differentiated adenocarcinoma arising in the Barrett epithelium of the distal oesophagus. The tumour invaded into but not through the muscle layer (T2) and involved 3 of 14 lymph nodes (N1). SK-GT-4 was found to be tumorigenic in athymic nu/nu mice.
Species
Homo sapiens (Human)
Source
Esophagus
Recommended Medium
RPMI-1640 + 2mM Glutamine + 10% Fetal Bovine Serum (FBS)
Disease
Esophageal Adenocarcinoma
Storage
Liquid Nitrogen (-180 °C).
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Never can cryopreserved cells be kept at -20 °C.
Synonyms
SKGT4; SK4
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

SK-GT-4 is a rigorously authenticated human esophageal adenocarcinoma (EAC) cell line established in 1989 from a well-differentiated adenocarcinoma arising from Barrett's mucosa in an 83-year-old male patient. As one of only ten EAC lines whose identity has been verified against original patient material through STR profiling, p53 mutation analysis, and xenograft histology, SK-GT-4 offers exceptional model fidelity in a field historically plagued by misidentified lines.

Molecularly, SK-GT-4 is comprehensively annotated through publicly available whole-genome sequencing data. It harbors a pathogenic KRAS mutation and an MSH2 missense variant, alongside recurrent copy-number alterations characteristic of EAC—including gains in ERBB2, MYC, MET, and SEMA5A, and losses in SMAD4 and CDKN2A. Its aneuploid karyotype (mode 59 chromosomes) and high mutational burden faithfully recapitulate the genomic complexity of primary EAC, closely mirroring TCGA profiles.

Functionally, SK-GT-4 demonstrates robust proliferative capacity and documented chemosensitivity to paclitaxel via G2/M arrest and caspase-3–mediated apoptosis. The line has been extensively utilized in high-throughput drug screening, circulating tumor cell detection validation, and mechanistic studies of EAC progression and metastasis. With authenticated origin, Barrett's-associated histogenesis, comprehensive genomic annotation, and proven experimental versatility, SK-GT-4 stands as a cornerstone model for advancing EAC biology and therapeutic discovery.

New N-Heterocyclic Carbene Gold and Platinum Complexes with 1,3-Dialkyl-4-anisyl-5-(4-chlorophenyl)imidazol-2-ylidene Ligands for the Treatment of Esophageal Adenocarcinoma

The dose- and time-dependent activity of the cationic NHC-gold(I) complexes 8 (G2) and 11 (G4) against esophageal adenocarcinoma (EAC) cells was investigated and compared with the activity of auranofin.

Their potential to induce apoptosis in SK-GT-4 and OE33 EAC cells was assessed using AnnexinV/PI assay and flow cytometry. Notably, cells treated with 8 and 11 (IC50 concentrations) for 72 h showed a considerable induction of both early and late apoptotic cells but only marginal numbers of necrotic cells, compared with untreated control populations (Fig. 1).

As another indicator of apoptosis induction, the activation of caspases 3 and 7 by complexes 8 and 11 was studied (Fig. 2). Both gold complexes 8 (1.7 and 1.9 µM, respectively) and 11 (0.9 and 0.7 µM, respectively) exhibited a 3–4-fold increase in caspase 3 and 7 activity in SK-GT-4 and FLO-1 EAC cells. The cells were then treated with auranofin, as previously reported, as it induces caspase 3/7 activity in a dose-dependent manner. However, when the cells were treated with 8 (G2) or auranofin, an equivalent dose of the most potent compound, 11 (G4), did not result in significant caspase 3/7 activity in SK-GT-4 and FLO-1 cells, suggesting the superiority of complex 11 (G4) in inducing apoptosis.

Gold complexes 8 (G2) and 11 (G4) induced early- and late-phase apoptosis in SK-GT-4 and OE33 cells, as assessed by Annexin-PI flow cytometry.
Fig. 1. Gold complexes 8 (G2) and 11 (G4) induced early- and late-phase apoptosis in SK-GT-4 and OE33 cells, as assessed by Annexin-PI flow cytometry (Ghosh, Hindole, et al., 2026).
Gold complexes 8 (G2) and 11 (G4) induced apoptosis in SK-GT-4 and FLO-1 cells, as assessed by activation of caspases 3 and 7 activity.
Fig. 2. Gold complexes 8 (G2) and 11 (G4) induced apoptosis in SK-GT-4 and FLO-1 cells, as assessed by activation of caspases 3 and 7 activity (Ghosh, Hindole, et al., 2026).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products